Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from VistaGen rapeutics

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stocks That Hit 52-Week Lows On Friday

During Friday's session, 61 companies made new 52-week lows.

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga's Top Ratings Upgrades, Downgrades For July 22, 2022

Stocks That Hit 52-Week Lows On Tuesday

Tuesday saw 37 companies set new 52-week lows.

inkl

Read news from The Economist, FT, and more,
with one subscription

Looking Into VistaGen Therapeutics's Return On Capital Employed

Looking Into VistaGen Therapeutics's Return On Capital Employed

Benzinga Pro data, VistaGen Therapeutics (NASDAQ:VTGN) reported Q4 sales of $38.90 thousand. Earnings fell to a loss of $16.69 million, resulting in a 58.41% decrease from last quarter.

Earnings Preview For VistaGen Therapeutics

Earnings Preview For VistaGen Therapeutics

VistaGen Therapeutics (NASDAQ:VTGN) is set to give its latest quarterly earnings report on Thursday, 2022-06-23. Here's what investors need to know before the announcement. Analysts estimate that VistaGen Therapeutics will report an earnings per share (EPS) of $-0.06.

VistaGen Therapeutics Earnings Perspective: Return On Capital Employed

VistaGen Therapeutics Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q3, VistaGen Therapeutics's (NASDAQ:VTGN) reported sales totaled $357.90 thousand. Despite a 17.66% increase in earnings, the company posted a loss of $10.54 million.

Organisations

Paramount Global

Micron Technology

Palantir Technologies

B of A Securities

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play